The HAND1 gene is located on chromosome 5q33.2 and consists of two exons spanning approximately 3.3 kilobases . The protein encoded by this gene is composed of 215 amino acids and contains a bHLH region, which is essential for its function as a transcription factor . The HAND1 protein has several potential phosphorylation sites, indicating that it may undergo post-translational modifications .
HAND1 is asymmetrically expressed in the developing ventricular chambers of the heart and plays a vital role in cardiac morphogenesis . It is involved in the formation of the right ventricle and aortic arch arteries, making it a key player in the development of congenital heart diseases . Additionally, HAND1 is expressed in extraembryonic membranes and certain neural crest derivatives .
In the adult heart, HAND1 is required for the ongoing expression of cardiac-specific genes . It binds to the DNA sequence 5’-NRTCTG-3’ (non-canonical E-box) and acts as a transcriptional repressor of SOX15 . HAND1 also stimulates the transcriptional activity of E12/E47 through degenerate E-boxes or inhibits their activity through perfect E-boxes .
Mutations in the HAND1 gene have been associated with various congenital heart defects, including atrial septal defect 5 and atrial heart septal defect . A frameshift mutation in the bHLH domain of HAND1 has been identified in patients with hypoplastic hearts, further highlighting its importance in cardiac development .
The recombinant form of HAND1 is used in various research applications to study its role in cardiac development and congenital heart diseases. Understanding the function and regulation of HAND1 can provide insights into the molecular mechanisms underlying heart development and potential therapeutic targets for congenital heart defects.